Spots Global Cancer Trial Database for standard of care
Every month we try and update this database with for standard of care cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) | NCT05685004 | Glioblastoma Mu... | TVI-Brain-1 Standard of Car... Radiotherapy Temozolomide | 18 Years - 80 Years | TVAX Biomedical | |
| A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer | NCT03602859 | Ovarian Neoplas... Ovarian, Fallop... | Niraparib Dostarlimab (TS... Standard of car... Dostarlimab-Pla... Niraparib-Place... | 18 Years - | Tesaro, Inc. | |
| Standard of Care Versus Hemopatch® During Liver Resection | NCT03166683 | Liver Cancer Hemorrhage Live... Bile Leak Surgery Tumor Liver | Hemopatch Standard of car... | 18 Years - | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | |
| Mindfulness Based Couples Therapy | NCT02349217 | Breast Cancer | Mindfulness-Bas... Self-Help Mater... Pain Assessment Questionnaires Neurocognitive ... Cortisol Tests Interviews | 21 Years - | M.D. Anderson Cancer Center | |
| De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE) | NCT06307015 | HPV Positive Or... | De-escalation Standard of car... | 18 Years - | Royal North Shore Hospital | |
| De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE) | NCT06307015 | HPV Positive Or... | De-escalation Standard of car... | 18 Years - | Royal North Shore Hospital | |
| A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components | NCT02549222 | Transfusion Rel... | Standard of Car... | - | Cerus Corporation | |
| SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice | NCT03820544 | Pancreatic Canc... | Endoscopic Retr... Standard of car... | 19 Years - | Thomas Jefferson University | |
| Stress-reducing Intervention in Urothelial Carcinoma | NCT06269536 | Bladder Cancer | HRV biofeedback | 18 Years - | Comenius University | |
| Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) | NCT05685004 | Glioblastoma Mu... | TVI-Brain-1 Standard of Car... Radiotherapy Temozolomide | 18 Years - 80 Years | TVAX Biomedical | |
| A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas | NCT03575351 | Lymphoma, Non-H... | Standard of Car... JCAR017 | 18 Years - 75 Years | Celgene | |
| Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer | NCT02369874 | Recurrent or Me... | MEDI4736 MEDI4736 + Trem... Standard of Car... | 18 Years - 96 Years | AstraZeneca | |
| Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors | NCT05733091 | Tumors | Standard of Car... | 18 Years - | M.D. Anderson Cancer Center | |
| Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) | NCT03739710 | Neoplasms | Docetaxel Feladilimab Ipilimumab GSK4428859A Dostarlimab GSK6097608 | 18 Years - | GlaxoSmithKline | |
| Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients | NCT01696539 | Prostatic Neopl... | Walking Interve... Standard of Car... | 40 Years - 80 Years | Örebro University, Sweden | |
| Effect of Peritoneal Fixation on Lymphocele Formation | NCT04853095 | Prostate Cancer Lymphocele Afte... | Peritoneal fixa... Standard of car... | 18 Years - | University Hospital Olomouc | |
| Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer | NCT03202446 | Breast Cancer S... Breast Cancer, ... Breast Cancer S... | 1% Glycated Chi... Photothermal La... Placebo Cyclophosphamid... Standard of Car... | 18 Years - | Eske Corporation S.A.C | |
| Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors | NCT05733091 | Tumors | Standard of Car... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer | NCT03472053 | Non Small Cell ... | BIO-11006 plus ... Standard of Car... | 18 Years - 70 Years | BioMarck Pharmaceuticals, Ltd. | |
| Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm | NCT02261051 | Cancer Advanced Cancer | Standard of car... | 18 Years - | Lancaster General Hospital | |
| Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases | NCT02759783 | Prostate Cancer Breast Cancer Carcinoma, Non-... | SBRT Standard of Car... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Effect of Perampanel on Peritumoral Hyperexcitability in HGG | NCT04497142 | Glioma, Maligna... Surgery Seizures | Perampanel Standard of Car... | 18 Years - | Dana-Farber Cancer Institute | |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids | NCT03194646 | Uterine Fibroid... | Vilaprisan (BAY... Vilaprisan (BAY... Vilaprisan (BAY... Standard of car... Vilaprisan (BAY... Vilaprisan (BAY... Vilaprisan (BAY... | 18 Years - | Bayer | |
| Comprehensive Palliative Care for Cancer Patients in Vietnam | NCT05103488 | Advanced Cancer Psychological D... Quality of Life | Comprehensive p... Standard of car... | 18 Years - 70 Years | Vietnam Palliative Health Care Society | |
| Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies | NCT02804945 | Blood And Marro... Adult Respirato... | Mesenchymal Ste... | 18 Years - | M.D. Anderson Cancer Center | |
| RCT of Mobile Apps & FitBit v. Usual Care | NCT03623464 | Pancreatic Canc... Gastric Cancer Hepatic Cancer Colon Cancer Rectal Cancer Small Bowel Can... | Mobile health a... Standard of car... | 18 Years - | Weill Medical College of Cornell University | |
| Biomarker-based Study in R/M SCCHN | NCT03088059 | Carcinoma, Squa... | Afatinib Palbociclib standard of car... IPH2201 Durvalumab Niraparib INCAGN01876 | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| The HOPE Trial and the SMART Study | NCT03022032 | Gynecologic Can... | Fitbit Zip HOPE App Standard of Car... Fitbit Charge 2 SMART Study Int... | 18 Years - | Dana-Farber Cancer Institute | |
| Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment | NCT02540174 | Upper Aerodiges... Lung Cancer | integrated addi... standard of car... | 18 Years - 65 Years | Centre Oscar Lambret | |
| African Cancer Genome: GMD | NCT05754658 | Breast Cancer Prostate Cancer | Standard of Car... Standard of Car... | 18 Years - 85 Years | Fox Chase Cancer Center | |
| Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM) | NCT05266430 | Choroidal Melan... Indeterminate L... | Standard of Car... AU-011 | 18 Years - | Aura Biosciences | |
| Stress-reducing Intervention in Urothelial Carcinoma | NCT06269536 | Bladder Cancer | HRV biofeedback | 18 Years - | Comenius University | |
| OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer | NCT04680260 | Colorectal Canc... Metastatic Canc... | Standard of car... Circulating tum... | 18 Years - | Aarhus University Hospital | |
| Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life | NCT01160367 | Amyotrophic Lat... GI Cancer Pancreatic Canc... | TAILORED Patien... standard of car... | 18 Years - | Johns Hopkins University | |
| Multi-scale Modeling of Breast Conserving Therapy | NCT02310711 | Breast Cancer | Standard of Car... | 30 Years - 80 Years | The Methodist Hospital Research Institute | |
| A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia | NCT04016636 | CLL | Standard of Car... | 18 Years - | Fundaleu | |
| DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma | NCT01353222 | Urothelial Carc... | DN24-02 Standard of Car... | 18 Years - | Dendreon | |
| Anti-Androgen Treatment for COVID-19 | NCT04446429 | COVID-19 SARS-CoV2 Androgenetic Al... Prostate Cancer Benign Prostati... SARS (Severe Ac... | Proxalutamide Standard of Car... | 18 Years - | Applied Biology, Inc. | |
| A Study of Participants With Advanced Prostate Cancer in Canada | NCT03501173 | Prostatic Neopl... | Standard of Car... | 21 Years - | Janssen Inc. | |
| Functional and Ultrasound Guided Resection of Glioblastoma | NCT05399524 | Glioma Glioblas... | Standard of Car... Additional pre-... | 18 Years - 70 Years | University of Oxford | |
| Addition of Everolimus to Standard of Care in Carcinoma Gallbladder | NCT05833815 | Gallbladder Can... | Everolimus 10 m... Standard of car... | 18 Years - 99 Years | Banaras Hindu University | |
| Effect of Peritoneal Fixation on Lymphocele Formation | NCT04853095 | Prostate Cancer Lymphocele Afte... | Peritoneal fixa... Standard of car... | 18 Years - | University Hospital Olomouc | |
| Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study | NCT06109961 | Inflammatory Bo... | Oxygen Gas for ... Standard of car... | 17 Years - | Ottawa Hospital Research Institute | |
| Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients | NCT04353973 | Cancer | Pre-Test Interv... Standard of Car... Post-Test Inter... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Preoperative Massage in Breast Surgery Patients | NCT01667328 | Anxiety Presurgical Anx... Breast Cancer | Massage therapy Standard of car... | 18 Years - | Vassar Brothers Medical Center | |
| African Cancer Genome: GMD | NCT05754658 | Breast Cancer Prostate Cancer | Standard of Car... Standard of Car... | 18 Years - 85 Years | Fox Chase Cancer Center | |
| Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts | NCT00459641 | Bone Cysts | I-040302 Standard of Car... | 6 Years - 16 Years | Kuros Biosurgery AG | |
| Radiotherapy for Extracranial Oligometastatic Breast Cancer | NCT04646564 | Breast Cancer M... | standard of car... radiotherapy + ... | 18 Years - 70 Years | ChineseAMS | |
| Addition of Aspirin to Standard of Care in Oral Cancer | NCT05865548 | Oral Cancer | Aspirin 150 mg Standard of car... | 18 Years - 99 Years | Banaras Hindu University | |
| Promoting Colorectal Cancer Screening in Rural Emergency Departments | NCT03473587 | Colorectal Canc... | Motivational in... Standard of car... | 50 Years - | University of Kentucky | |
| Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC). | NCT05681039 | Squamous Cell C... Oral Cavity Squ... | Tiragolumab Atezolizumab Standard of Car... Questionnaires Cisplatin Carboplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer | NCT03778931 | Breast Cancer | Elacestrant Standard of Car... | 18 Years - | Stemline Therapeutics, Inc. | |
| Use of Pedometer Following Radical Cystectomy | NCT04305730 | Bladder Cancer Ileus Narcotic Use | Use of a pedome... Standard of car... | 18 Years - 75 Years | Benaroya Research Institute | |
| Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy | NCT06296147 | Prostate Cancer | Virtual Reality... Aromatherapy Pa... Standard of Car... | 18 Years - | University of Pittsburgh | |
| Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis | NCT02138838 | Chronic Kidney ... | Cinacalcet HCl Standard of Car... | 6 Years - 17 Years | Amgen | |
| Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients | NCT01696539 | Prostatic Neopl... | Walking Interve... Standard of Car... | 40 Years - 80 Years | Örebro University, Sweden | |
| Testing a Personalize Medication Log for Patients With Lymphoma | NCT02370446 | Lymphoma | personalized me... standard of car... questionnaires Cognitive Inter... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy | NCT06367257 | Squamous Cell C... | App Usage Standard of Car... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype | NCT05574673 | Ovarian Cancer Primary Periton... Fallopian Tube ... | Standard of car... | 18 Years - 100 Years | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | |
| Trial of AEO in New Glioblastoma (GBM) | NCT04450160 | Glioblastoma Mu... | Anhydrous Enol-... Standard of Car... | 18 Years - | MetVital, Inc. | |
| Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy | NCT04295447 | Prostatic Neopl... | Standard of car... Apalutamide 60M... | 18 Years - | Universität Münster | |
| Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy | NCT02956473 | Breast Cancer | Supine MRI Neoadjuvant The... Ultrasound Mammography Standard of Car... Standard MRI | 18 Years - | Dana-Farber Cancer Institute | |
| Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer | NCT04405401 | Lung Cancer Met... | SABR Standard of car... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) | NCT06401980 | Metastatic Cast... | Darolutamide Standard of car... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Anti-Androgen Treatment for COVID-19 | NCT04446429 | COVID-19 SARS-CoV2 Androgenetic Al... Prostate Cancer Benign Prostati... SARS (Severe Ac... | Proxalutamide Standard of Car... | 18 Years - | Applied Biology, Inc. | |
| Stress-Reducing Intervention in Patients With Colorectal and Breast Cancer | NCT06281145 | Breast Cancer Colon Cancer | Heart-rate vari... | 18 Years - | Comenius University | |
| Sleep and Survival in Colorectal Cancer | NCT03254836 | Colorectal Neop... Circadian Rhyth... Depression Quality of Life Sleep | Standard of car... | 18 Years - | Zealand University Hospital | |
| Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening | NCT06184594 | Colorectal Canc... | eNav Standard of Car... | 45 Years - 75 Years | Icahn School of Medicine at Mount Sinai | |
| A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma | NCT05932290 | Multiple Myelom... | Elranatamab Standard of car... | 18 Years - | Pfizer | |
| Impact of Digital Tools on the Quality of Bowel Preparation for Colonoscopy | NCT05734079 | Colonoscopy | Standard of car... Standard of car... Standard of car... | 18 Years - | Ziv Hospital | |
| Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism | NCT01439867 | Chronic Kidney ... Hyperparathyroi... | Cinacalcet hydr... Standard of Car... | 28 Days - 2189 Days | Amgen | |
| Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration | NCT04362449 | Gallbladder Can... | Shortened hydra... Standard of car... | 18 Years - | Imperial College Healthcare NHS Trust | |
| Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms | NCT03763253 | Prostate Cancer Metastatic Pros... | Standard of Car... Minimally Invas... Radical Therapy... | 18 Years - | Imperial College London | |
| Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML | NCT01883362 | Acute Myeloid L... | Midostaurin Standard of Car... | 18 Years - 70 Years | Novartis | |
| Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy | NCT01378143 | Colorectal Canc... | OCZ103-OS [pent... | 18 Years - | Oncozyme Pharma Inc. | |
| A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database | NCT05236257 | Locally Advance... Infantile Fibro... | Larotrectinib (... Standard of Car... | - 21 Years | Bayer | |
| Use of Pedometer Following Radical Cystectomy | NCT04305730 | Bladder Cancer Ileus Narcotic Use | Use of a pedome... Standard of car... | 18 Years - 75 Years | Benaroya Research Institute | |
| Functional and Ultrasound Guided Resection of Glioblastoma | NCT05399524 | Glioma Glioblas... | Standard of Car... Additional pre-... | 18 Years - 70 Years | University of Oxford | |
| An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer | NCT05454488 | Prostate Cancer | Focal Cryoablat... Standard of Car... Quality-of-life... | 18 Years - | M.D. Anderson Cancer Center | |
| Decision Impact Study of PreciseDx Breast | NCT06309615 | Breast Cancer | Standard of Car... | 23 Years - | Precise Dx, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
